Roubaix Capital, LLC Champions Oncology, Inc. Transaction History

Roubaix Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$9.11 - $10.96 $3.2 Million - $3.85 Million	-351,507 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$8.45 - $11.72 $610,166 - $846,289	72,209 Added 25.85%	351,507 $3.61 Million
Q1 2021 Apr 29, 2021	BUY	$10.61 - $13.75 $772,365 - $1 Million	72,796 Added 35.25%	279,298 $3.16 Million
Q4 2020 Feb 11, 2021	BUY	$8.39 - $13.27 $1.73 Million - $2.74 Million	206,502 New	206,502 $2.23 Million

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $106M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Roubaix Capital, LLC with notifications on news.